Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline to Reduce Post-angioplasty Restenosis in Lower Limb Arterial Disease
2012-000868-15Phase 3Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in arteriosclerosis obliterans, sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Six-minute walk test. Started Jun 2012; status: active.
02
Drugs
pentoxifylline
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2012-000868-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000868-15.